Skip to main content

Table 2 Clinical and laboratory characteristics of workers between day and night shifts in Southern Brazil

From: Night shift work, short sleep and obesity

Variables

General

Women

Men

Day

Night

p

Day

Night

p

Day

Night

p

Weight (kg) (n = 200)

72.4 ± 15.5

77.9 ± 15.4

0.011**

69 ± 13.1

72.6 ± 12.8

0.128**

80.5 ± 18.0

89.8 ± 14.2

0.030*

BMI (n = 200)

26.4 ± 4.6

28.7 ± 4.8

< 0.001**

26.3 ± 4.6

28.4 ± 4.9

0.014**

26.7 ± 4.7

29.5 ± 4.3

0.018*

AC (n = 200)

89.4 ± 12.3

96.4 ± 12.1

< 0.001**

88.7 ± 12.0

92.9 ± 12.7

0.009**

92.9 ± 12.7

100.7 ± 11.7

0.017*

Presence MS

19 (29.2)

32 (43.2)

0.125##

13 (28.9)

21 (40.4)

0.332##

6 (30.0)

11 (40.0)

0.315##

SAP-right (n = 200)

116.0 (109.3–127.8)

120.0 (110.0–131.0)

0.240**

116.0 (109.0–127.5)

120.0 (110.0–129.0)

0.591**

121.0 (111.0–128.0)

120.0 (112.5–138.0)

0.180**

SAP-left (n = 200)

117.0 (108.0–125.0)

119.0 (110.0–130.0)

0.196**

115.0 (108.0–123.0)

118.0 (109.0–127.0)

0.424**

119.0 (111.0–131.0)

125.0 (112.5–139.0)

0.223**

DAP right (n = 200)

75.5 (68.0–84.8)

78.0 (70.5–86.0)

0.269**

76.0 (68.0–85.5)

77.0 (70.0–84.0)

0.790**

75.7 ± 9.8

81.0 ± 11.2

0.060*

DAP left (n = 200)

76.4 ± 11.1

77.5 ± 10.5

0.458*

77.0 (68.0–84.8)

77.0 (69.5–83.0)

0.890**

75.6 ± 8.9

79.1 ± 12.0

0.205*

TC

192.7 ± 32.5

200.0 ± 36.0

0.225*

195.7 ± 33.4

200.5 ± 32.4

0.474*

185.2 ± 29.8

198.5 ± 44.9

0.294*

HDL

49 (44–61.5)

47 (40–55.3)

0.070**

55.3 ± 10.5

50.5 ± 12.2

0.041*

44.0 (36.8–48.5)

43.0 (39.8–47.5)

0.980**

LDL

121.0 ± 28.9

129.7 ± 35.0

0.155*

123.4 ± 30.7

127.6 ± 27.1

0.522*

116.9 ± 25.5

134.9 ± 50.2

0.183*

Triglycerides

97 (58.3–133.5)

100.0 (74.5–147.0)

0.257**

97.0 (58.0–125.0)

91.5 (68.5–135.4)

0.534**

100.0 (62.0–163.0)

120.0 (82.0–172.0)

0.294**

Glycemia

89.0 (81.0–95.8)

90.5 (85.0–99.8)

0.124**

89.0 (81.0–90.0)

89.0 (84.0–96.0)

0.215**

94.5 (80.8–99.0)

96.0 (88.0–108.0)

0.267**

HbA1c

5.4 (5.1–5.7)

5.5 (5.1–6.0)

0.271**

5.4 ± 0.5

5.5 ± 0.6

0.574

5.4 (5.2–5.5)

5.5 (5.1–6.6)

0.251**

Insulin

11.0 (8.5–15.8)

10.5 (7.6–13.9)

0.693**

11.1 (8.6–15.9)

12.2 (7.7–16.1)

0.789**

10.6 (7.5–15.2)

9.7 (7.5–10.7)

0.287**

Creatinine

0.7 (0.6–0.8)

0.7 (0.6–0.8)

0.487**

0.6 (0.5–0.7)

0.7 (0.6–0.7)

0.139**

0.9 (0.8–1.0)

0.9 (0.7–1.0)

0.657**

CKD-EPI GFR

111.0 (101.0–122.0)

104.5 (93.0–113.0)

0.017**

112.1 ± 14.4

103.7 ± 14.5

0.006*

102.8 ± 13.7

99.6 ± 19.5

0.583*

Urea

31.0 (26.0–37.0)

31.0 (27.0–38.0)

0.745**

29.0 (24.8–35.0)

30.0 (27.0–34.0)

0.429**

35.0 (29.5–41.0)

35.0 (30.0–41.0)

0.925**

  1. Quantitative variables with symmetrical distribution described by mean ± deviation. Quantitative variables with asymmetrical distribution described by the median (P25–P75). Categorical variables described by frequencies and percentages. Lab tests information were available in 180 workers
  2. AC abdominal circumference in cm, BMI body mass index, CK EPI GFR chronic kidney disease epidemiology collaboration estimate glomerular filtrate rate, DAP diastolic arterial pressure (mmHg), HbA1c glycated hemoglobin, HDL high density lipoprotein, LDL low density lipoprotein, MS metabolic syndrome, SAP systolic arterial pressure (mmHg), TC total cholesterol
  3. * Student’s t test; ** Mann–Whitney test
  4. #Pearson’ s Chi Square test; ##Pearson’s Chi Square test with continuity correction
Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us